Cargando…
Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
SIMPLE SUMMARY: The development of blood cancers is a complex process that involves the acquisition of specific blood disorders that precede cancer. These blood disorders are often driven by the accumulation of genetic abnormalities, which are discussed in this review. Likewise, predicting the rate...
Autores principales: | Veiga, Camilla Bertuzzo, Lawrence, Erin M., Murphy, Andrew J., Herold, Marco J., Dragoljevic, Dragana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073047/ https://www.ncbi.nlm.nih.gov/pubmed/33921778 http://dx.doi.org/10.3390/cancers13081968 |
Ejemplares similares
-
Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis
por: Inoue, Daichi, et al.
Publicado: (2016) -
Hematopoiesis of Indeterminate Potential and Atherothrombotic Risk
por: Murphy, Andrew J., et al.
Publicado: (2022) -
Clonal hematopoiesis and cardiovascular disease: deciphering interconnections
por: Stein, Anna, et al.
Publicado: (2022) -
Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells
por: Kandarakov, Oleg, et al.
Publicado: (2020) -
Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis
por: Kraakman, Michael J, et al.
Publicado: (2016)